← Back to LENZ

LENZ Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 05/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/11/2025Mar 2024Filed 05/11/2025
$5.5$1.9$13$5$0$0$0
−$32−$41−$17−$15−$15−$10−$10−$17
−$1.02−$1.32−$0.59−$0.53−$0.53−$0.38−$0.40−$3.53
313129282827264.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.